Molnupiravir will not replace vaccines but reduce transmission


Added aid to curb virus: Molnupiravir is able to reduce 50% of hospital admissions and is effective against more infectious variants of Covid-19 including Gamma, Delta and Mu, says a research. — Reuters

PETALING JAYA: The antiviral drug Molnupiravir will not replace vaccines but will offer an alternative in treating Covid-19 patients, health experts have pointed out.

Universiti Malaya epidemiologist Prof Datuk Dr Awang Bulgiba Awang Mahmud said the drug could reduce transmission in patients.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Nation

All about EPF’s Account 3
Taiwanese superstars scale Mt Kinabalu
Feared extinct, toad hops back into sight
Interim report: Helicopters in Lumut crash airworthy
M’sia ceased distributing AstraZeneca vaccine ‘long ago’, says doctor
Malaysia a magnet for expats
SPM 2023 results to be announced on May 27
Only UN sanctions recognised
Expert: Upgrades needed to become regional research hub
Inmate’s tearful reunion with daughter

Others Also Read